Financhill
Back

Protagonist Therapeutics Stock Price Chart

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PTGX is experiencing buying pressure, which is a positive indicator for future bullish movement.

Protagonist Therapeutics Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 41.58 Buy
20-day SMA: 44.66 Buy
50-day SMA: 45.25 Buy
200-day SMA: 35.78 Buy
8-day EMA: 42.72 Buy
20-day EMA: 43.78 Buy
50-day EMA: 44.02 Buy
200-day EMA: 36.88 Buy

Protagonist Therapeutics Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.01 Sell
Relative Strength Index (14 RSI): 57.05 Buy
Chaikin Money Flow: 782176 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (42.22 - 47.9) Buy
Bollinger Bands (100): (38.27 - 46.31) Buy

Protagonist Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Protagonist Therapeutics Stock

Is Protagonist Therapeutics Stock a Buy?

PTGX Technical Analysis vs Fundamental Analysis

Sell
45
Protagonist Therapeutics (PTGX) is a Sell

Is Protagonist Therapeutics a Buy or a Sell?

Protagonist Therapeutics Stock Info

Market Cap:
2.77B
Price in USD:
46.46
Share Volume:
1.32M

Protagonist Therapeutics 52-Week Range

52-Week High:
48.89
52-Week Low:
16.80
Sell
45
Protagonist Therapeutics (PTGX) is a Sell

Protagonist Therapeutics Share Price Forecast

Is Protagonist Therapeutics Stock a Buy?

Fundamental Analysis of Protagonist Therapeutics

Is Protagonist Therapeutics a good investment?

  • Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.45 per share, and a decrease next year of $3.44 per share.

Technical Analysis of Protagonist Therapeutics

Should I short Protagonist Therapeutics stock?

* Protagonist Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.